Jiejiu Lu

Guangxi Medical University — China

Medicine · Health Sciences

7h-index103citations15works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotics Pharmacokinetics and Efficacy(8), Renal Transplantation Outcomes and Treatments(3), Chronic Kidney Disease and Diabetes(3), Hemoglobinopathies and Related Disorders(3), Antimicrobial Resistance in Staphylococcus(2)

Publications15 total

Population pharmacokinetics of colistin sulfate in patients on continuous veno-venous hemodiafiltration
Science Progress·2025Open Access
Sex differences in <scp>LDL</scp>‐C reduction response to evolocumab: A propensity score matching analysis
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy·2024· 1 citedOpen Access
Population pharmacokinetics of cyclosporine A in pediatric patients with thalassemia undergoing allogeneic hematopoietic stem cell transplantation
European Journal of Clinical Pharmacology·2024· 2 cited
Serum Cystatin C as a Risk Factor for Supratherapeutic Digoxin Concentration in Elderly Patients with Heart Failure and Chronic Kidney Disease
American Journal of Cardiovascular Drugs·2024
Dosage Optimization of Digoxin in Older Patients with Heart Failure and Chronic Kidney Disease: A Population Pharmacokinetic Analysis
Drugs & Aging·2023· 1 cited
Comparison of Vancomycin Clearance Between Augmented Renal Clearance and Normal Renal Function in Critically Ill Infants: A Population Pharmacokinetics Study
The Journal of Clinical Pharmacology·2022· 4 cited
Influential Factors and Efficacy Analysis of Tacrolimus Concentration After Allogeneic Hematopoietic Stem Cell Transplantation in Children with β-Thalassemia Major
Pharmacogenomics and Personalized Medicine·2021· 2 citedOpen Access
Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents
Journal of Clinical Pharmacy and Therapeutics·2021· 12 cited
Initial Dosage Optimization of Tacrolimus in Pediatric Patients With Thalassemia Major Undergoing Hematopoietic Stem Cell Transplantation Based on Population Pharmacokinetics
Annals of Pharmacotherapy·2020· 11 cited
Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children
Journal of Clinical Pharmacy and Therapeutics·2020· 24 cited
A Population Pharmacokinetics Model for Vancomycin Dosage Optimization Based on Serum Cystatin C
European Journal of Drug Metabolism and Pharmacokinetics·2020· 11 cited
Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population
European Journal of Drug Metabolism and Pharmacokinetics·2019· 9 cited
Development and comparison of population pharmacokinetic models of vancomycin in neurosurgical patients based on two different renal function markers
Journal of Clinical Pharmacy and Therapeutics·2019· 16 cited
Duration of ulcerative Mucositis (OM) and outcomes of Allogeneic (AL) Hematopoietic Stem Cell Transplantation (HSCT) in patients with hematologic malignancies
Biology of Blood and Marrow Transplantation·2006· 1 citedOpen Access
A population pharmacokinetic model for bevacizumab
Clinical Pharmacology & Therapeutics·2004· 9 cited

Frequent Co-authors

Taotao Liu(11), Chunle Lv(7), Ren Zhang(5), Chengxin Li(3), Siru Zhou(3), Yinyi Wei(3), Qiaochuan Li(2), Jing Li(2), Ming Chen(2), Huang Guang-ming(2), Jianying Qi(2), Rongda Cai(2), Limin Zhang(2), Tingqing Wu(2), Tianmin Huang(2), Yun Wu(2), Lulu Niu(2), Yang Xiao(2), Xin Chen(2), Yong‐Jun Liu(2)